Cipla - Quaterly Results

25 Jan 2022 Evaluate
The December 2021 quarter revenue stood at Rs. 39547.90 millions, up 5.98% as compared to Rs. 37315.50 millions during the corresponding quarter last year.Profit after tax improved marginally to Rs. 7308.30  millions for the quarter ended December 2021 from Rs. 6989.30 millions of corresponding previous quarter.The company reported a good operating profit of 11129.80 millions compared to 10922.70 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202112 202012 % Var 202112 202012 % Var 202103 202003 % Var
Sales 39547.90 37315.50 5.98 119072.30 106674.60 11.62 139005.80 126591.50 9.81
Other Income 730.00 961.20 -24.05 3503.90 1809.50 93.64 2302.80 8928.50 -74.21
PBIDT 11129.80 10922.70 1.90 35186.80 32528.10 8.17 39518.40 36001.40 9.77
Interest 55.50 103.30 -46.27 211.50 362.30 -41.62 450.70 360.50 25.02
PBDT 11074.30 10819.40 2.36 34975.30 32165.80 8.73 39067.70 35640.90 9.61
Depreciation 1339.50 1345.70 -0.46 4099.00 4191.00 -2.20 5561.10 5997.80 -7.28
PBT 9734.80 9473.70 2.76 30876.30 27974.80 10.37 33506.60 29643.10 13.03
TAX 2426.50 2484.40 -2.33 7826.60 7426.10 5.39 8823.80 6461.40 36.56
Deferred Tax -159.10 -31.60 403.48 -276.40 -290.90 -4.98 -220.00 1001.80 -121.96
PAT 7308.30 6989.30 4.56 23049.70 20548.70 12.17 24682.80 23181.70 6.48
Equity 1613.60 1612.90 0.04 1613.60 1612.90 0.04 1612.90 1612.50 0.02
PBIDTM(%) 28.14 29.27 -3.86 29.55 30.49 -3.09 28.43 28.44 -0.03

Cipla Share Price

1520.55 -0.65 (-0.04%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×